BTC $62,190.57 +0.83%
ETH $1,735.05 +2.19%
BNB $566.85 +0.90%
XRP $1.12 +2.54%
SOL $81.55 +0.94%
TRX $0.3202 +0.78%
DOGE $0.0765 +3.19%
ADA $0.1757 +10.09%
BCH $228.32 +4.29%
LINK $7.86 +1.28%
HYPE $70.03 +6.72%
AAVE $88.69 +1.35%
SUI $0.7563 +2.54%
XLM $0.2020 +0.79%
ZEC $457.77 +4.62%
BTC $62,190.57 +0.83%
ETH $1,735.05 +2.19%
BNB $566.85 +0.90%
XRP $1.12 +2.54%
SOL $81.55 +0.94%
TRX $0.3202 +0.78%
DOGE $0.0765 +3.19%
ADA $0.1757 +10.09%
BCH $228.32 +4.29%
LINK $7.86 +1.28%
HYPE $70.03 +6.72%
AAVE $88.69 +1.35%
SUI $0.7563 +2.54%
XLM $0.2020 +0.79%
ZEC $457.77 +4.62%

Data: Pioneer Pharmaceutical Biotechnology surged over 240% during trading, having previously announced plans to acquire all shares of Conflux

2025-07-02 10:58:01
Collection

ChainCatcher news, Hong Kong listed company Pioneer Pharma Biotechnology (00399) saw a significant increase in trading volume this morning, with a peak rise of nearly 240%, reaching a maximum price of 0.7 HKD, before retreating to around 0.34 HKD.

Previously, the company announced plans to acquire 100% equity of the blockchain project Conflux to expand its presence in the blockchain field, with two founding members of Conflux currently serving as its executive directors.

app_icon
ChainCatcher Building the Web3 world with innovations.